EFFICACY OF BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH CARFILZOMIB-REFRACTORY MYELOMA IN THE UK NCRI CARDAMON TRIAL
Phillips, E., Wilson, W., Benjamin, R., Popat, R., Braganza, N., Clifton-Hadley, L., Bygrave, C., Cavenagh, J., Chapman, M., Owen, R., Ramasamy, K., Sive, J., Streetly, M., Nador, G., Arnott, S., HassVolume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000560684.31002.b1
Date:
June, 2019
File:
PDF, 344 KB
2019